《LANCET,4月7日,Invisible spread of SARS-CoV-2 – Authors' reply》

  • 来源专题:COVID-19科研动态监测
  • 编译者: xuwenwhlib
  • 发布时间:2020-04-08
  • Invisible spread of SARS-CoV-2 – Authors' reply

    Adam J Kucharski

    Rosalind M Eggo

    Published:April 07, 2020DOI:https://doi.org/10.1016/S1473-3099(20)30275-9

    We thank Nian Xiong and colleagues for their response to our Article.1 Although we separated individuals into exposed and infectious compartments in the basic model, we also considered a sensitivity analysis whereby people became infectious in the second half of their incubation period, and obtained the same conclusion (Article appendix p 12). We allowed the reproduction number, R, to vary over time in our model, rather than simply fix this value, to capture possible variation in transmission as a result of control measures and behaviour change. However, our median estimate for the reproduction number in mid-January of 2·4 is consistent with other estimates from the same period by use of a fixed R.2 As there is a delay from infection to symptom onset to hospitalisation, our model incorporated a delay to account for the time it takes for changes in transmission to be reflected in the observed data. Our estimate for transmission reduction was similar to that in another study, which focused on case counts in Wuhan and estimated that R had declined to around 1·3 by the last week of January, 2020.3 We disagree that our assumed incubation period was inappropriate; our assumption of a 5·2 day (SD 3·7) value is consistent with later studies that have estimated a similar value.4

  • 原文来源:https://www.thelancet.com/journals/laninf/article/PIIS1473-3099(20)30275-9/fulltext
相关报告
  • 《LANCET,4月7日,Invisible spread of SARS-CoV-2》

    • 来源专题:COVID-19科研动态监测
    • 编译者:xuwenwhlib
    • 发布时间:2020-04-08
    • nvisible spread of SARS-CoV-2 Nian Xiong Tao Wang Zhicheng Lin Published:April 07, 2020DOI:https://doi.org/10.1016/S1473-3099(20)30263-2 We read with interest Adam Kucharski and colleagues' mathematical modelling study of the early dynamics of coronavirus disease 2019 (COVID-19).1 We agree that a stochastic transmission model might best fit with the reality around the Huanan Seafood Wholesale Market, which was the origin of the COVID-19 outbreak2 and 1 mile away from our hospitals in Wuhan. We appreciate the work making use of different datasets and considering travel. However, we have concerns about the clinical and strategic values of this work.
  • 《Lancet,3月6日,Managing neonates with respiratory failure due to SARS-CoV-2 – Authors' reply》

    • 来源专题:COVID-19科研动态监测
    • 编译者:xuwenwhlib
    • 发布时间:2020-03-07
    • Managing neonates with respiratory failure due to SARS-CoV-2 – Authors' reply Jianhui Wang Yuan Shi Published:March 06, 2020DOI:https://doi.org/10.1016/S2352-4642(20)30072-9 We thank Daniele De Luca for his reflections on our Comment.1 We agree that testing all admitted neonates for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is not necessary. We recommended screening all newly admitted infants at high risk of coronavirus disease 2019 (COVID-19) on the basis of their family history. Only high-risk patients should receive a nucleic acid test for SARS-CoV-2. However, all high-risk neonates should be isolated in a single room, preferably in a neonatal intensive care unit (NICU). Based on existing experience, some patients initially present with mild flu-like symptoms but rapidly develop respiratory distress and multiple organ failure. Admitting all neonates with COVID-19 to the NICU could ensure the availability of close monitoring and necessary interventions.2 However, each clinical setting should consider its bed surge capacity in case of a COVID-19 outbreak and adopt a flexible and variable approach to admitting patients.